Jelfa's privatization attracts interest from six drugs firms

Although the privatization of Jelfa is still being finalized by the government, six companies have so far declared their interest in purchasing a 30% stake in it. These companies currently include Polfa Kutno, as well as such potential foreign investors as Teva, the largest generic drugs manufacturer in the world, the American Ivax and Italy's Recordati. While Polfa intends to pay zł.49 a share, according to analysts specializing in the pharmaceutical sector, its competitors may well be prepared to pay up to zł.70 a share. (Parkiet, p.1) J.J.